{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:31:51Z","timestamp":1771983111829,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T00:00:00Z","timestamp":1430956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s15010-015-0792-8","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T05:22:57Z","timestamp":1430889777000},"page":"103-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rapid regression of Kaposi\u2019s sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy"],"prefix":"10.1007","volume":"44","author":[{"given":"Gundolf","family":"Sch\u00fcttfort","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"de Leuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"Kann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Blume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Reinhard","family":"Brodt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,7]]},"reference":[{"key":"792_CR1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.canep.2014.09.009","volume":"38","author":"CA Stiller","year":"2014","unstructured":"Stiller CA, Trama A, Brewster DH, Verne J, Bouchardy C, Navarro C, et al. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project. Cancer Epidemiol. 2014;38:670\u20138.","journal-title":"Cancer Epidemiol"},{"key":"792_CR2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjc.6605756","volume":"103","author":"S Franceschi","year":"2010","unstructured":"Franceschi S, Lise M, Clifford GM, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103:416\u201322.","journal-title":"Br J Cancer"},{"key":"792_CR3","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2005.05.4072","volume":"24","author":"S Grabar","year":"2006","unstructured":"Grabar S, Abraham B, Mahamat A, Del Giudice P, Rosenthal E, Costagliola D. Differential impact of combination antiretroviral therapy in preventing Kaposi\u2019s sarcoma with and without visceral involvement. JCO. 2006;24:3408\u201314.","journal-title":"JCO"},{"key":"792_CR4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.25547","volume":"117","author":"EP Simard","year":"2011","unstructured":"Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer. 2011;117:1089\u201396.","journal-title":"Cancer"},{"key":"792_CR5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/QAD.0b013e3282202b7d","volume":"21","author":"AS Laney","year":"2007","unstructured":"Laney AS, Cannon MJ, Jaffe HW, et al. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi\u2019s sarcoma. AIDS. 2007;21:1541\u20135.","journal-title":"AIDS"},{"key":"792_CR6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/656045","volume":"202","author":"V Marshall","year":"2010","unstructured":"Marshall V, Martr\u00f3 E, Labo N, et al. Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study. J Infect Dis. 2010;202:1126\u201335.","journal-title":"J Infect Dis"},{"key":"792_CR7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM200011093431904","volume":"343","author":"J Pauk","year":"2000","unstructured":"Pauk J, Huang ML, Brodie SJ, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000;343:1369\u201377.","journal-title":"N Engl J Med"},{"key":"792_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/QCO.0b013e3280143919","volume":"20","author":"F Pica","year":"2007","unstructured":"Pica F, Volpi A. Transmission of human herpesvirus 8: an update. Curr Opin Infect Dis. 2007;20:152\u20136.","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"792_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s15010-012-0281-2","volume":"41","author":"S Bella Di","year":"2013","unstructured":"Di Bella S, Petrosillo N. Kaposi\u2019s sarcoma symmetric mucosal lesions. Infection. 2013;41(1):297.","journal-title":"Infection"},{"key":"792_CR10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s15010-013-0508-x","volume":"41","author":"JP Servato","year":"2013","unstructured":"Servato JP, Loyola AM, Spini PH, Spini TH, de Faria PR, Cardoso SV. Regression of oral Kaposi\u2019s sarcoma antiretroviral therapy. Infection. 2013;41:1201\u20132.","journal-title":"Infection"},{"key":"792_CR11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/QAD.0b013e32832d080d","volume":"23","author":"M Bower","year":"2009","unstructured":"Bower M, Weir J, Francis N, et al. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi\u2019s sarcoma. AIDS. 2009;23:1701\u20136.","journal-title":"AIDS"},{"key":"792_CR12","first-page":"779","volume":"27","author":"AM Cattelan","year":"2005","unstructured":"Cattelan AM, Calabro ML, De Rossi A, et al. Long-term clinical outcome of AIDS-related Kaposi\u2019s sarcoma during highly active antiretroviral therapy. Int J Oncol. 2005;27:779\u201385.","journal-title":"Int J Oncol"},{"key":"792_CR13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.2013.51.6757","volume":"32","author":"M Bower","year":"2014","unstructured":"Bower M, Dalla Pria A, Coyle C, et al. Prospective stage-stratified approach to AIDS-related Kaposi\u2019s sarcoma. J Clin Oncol. 2014;32:409\u201314.","journal-title":"J Clin Oncol"},{"key":"792_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm0302-225","volume":"8","author":"C Sgadari","year":"2002","unstructured":"Sgadari C, Barillari G, Toschi E, et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med. 2002;8:225\u201332.","journal-title":"Nat Med"},{"key":"792_CR15","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AAC.01295-10","volume":"55","author":"S Gantt","year":"2011","unstructured":"Gantt S, Carlsson J, Ikoma M, et al. The HIV protease inhibitor nelfinavir inhibits Kaposi sarcoma-associated herpesvirus replication in vitro. Antimicrob Agents Chemother. 2011;55:2696\u2013703 (Epub ahead of print).","journal-title":"Antimicrob Agents Chemother"},{"key":"792_CR16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.bjc.6603056","volume":"94","author":"V Martinez","year":"2006","unstructured":"Martinez V, Caumes E, Gambotti L, et al. Remission from Kaposi\u2019s sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy. Br J Cancer. 2006;94:1000\u20136.","journal-title":"Br J Cancer"},{"key":"792_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcv.2014.03.002","volume":"60","author":"S Gantt","year":"2014","unstructured":"Gantt S, Cattamanchi A, Krantz E, et al. Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy. J Clin Virol. 2014;60:127\u201332.","journal-title":"J Clin Virol"},{"issue":"3","key":"792_CR18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1468-1293.2011.00955.x","volume":"13","author":"F Asiimwe","year":"2012","unstructured":"Asiimwe F, Moore D, Were W, Nakityo R, Campbell J, Barasa A, et al. Clinical outcomes of HIV-infected patients with Kaposi\u2019s sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda. HIV Med. 2012;13(3):166\u201371.","journal-title":"HIV Med."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-015-0792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-015-0792-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-015-0792-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:34:27Z","timestamp":1748378067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-015-0792-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1007\/s15010-015-0792-8","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,7]]}}}